IRVINE, Calif.--ISTA Pharmaceuticals (Nasdaq: ISTA) plans to offer 4.5 million shares of its common stock in an underwritten public offering.

ISTA also intends to grant an option to the underwriters to purchase up to an additional 675,000 shares of common stock to cover over-allotments, if any. All of the shares are being sold by the company.